Ledger.Open graph →
SEC Form D · Amendment · filed December 2, 2016

RECURSION PHARMACEUTICALS, INC

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

H. P. Fell · SALT LAKE CITY, UTDirectorBlake C. Borgeson · Salt Lake City, UTExec · Director · PromoterZavain P. Dar · MENLO PARK, CADirectorDean Y. Li · Salt Lake City, UTExec · PromoterChristopher C. Gibson · Salt Lake City, UTExec · Director · PromoterReid P. Hutchins · GLENN FALLS, NYDirectorRan S. Nussbaum · Lexington, MAExec · Director · PromoterJonathan S. Katz · New York, NYDirectorKelsey Recht · New York, NYDirectorAnders Richardson · LOS ANGELES, CADirectorJulius S. Knowles · Lexington, MAExec · Director · PromoterAlon S. Lazarus · Lexington, MAExec · PromoterJordan A. Grayson · Orinda, CAExec · Director · PromoterNeelima Shukla · Denver, COExec · Director · PromoterRyan Holoubek · Denver, COExec · PromoterVasudev Kulkarni · New York, NYDirectorVictoria L. Dixon · Sulphur Springs, TXDirectorRon R. Kelly · San Jose, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗